Investor Relations

SEC Filings

Document Details

Filing Date
Apr 19, 2024
Document Date
Jun 10, 2024
Form Description
A preliminary proxy statement providing notification matters to be brought to a vote
Filing Group
Proxy Filings
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.